HCA Healthcare, Inc. (HCA) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-03-31..
- Stock-based compensation / revenue · 12 months: Value 0.51%; Formula and calculation Share-based compensation / revenue. Period ending 2026-03-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.51% | Share-based compensation / revenue. Period ending 2026-03-31. $389.00M ÷ $76.39B × 100 ≈ 0.51% |
| Interest coverage · 12 months | (m) | Operating income ÷ reported interest expense. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 76.39B USD | |
| Stock-based compensation | 389.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | (m) | |
| Interest expense · reported / estimated | 2.29B USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | (m) | $76.39B | $389.00M | (m) | $2.29B | (m) | 0.51% | (m) | Reported |
| 2025-12-31 | (m) | $75.60B | $401.00M | (m) | $2.25B | (m) | 0.53% | (m) | Reported |
| 2025-09-30 | (m) | $74.37B | $386.00M | (m) | $2.20B | (m) | 0.52% | (m) | Reported |
| 2025-06-30 | (m) | $72.70B | $358.00M | (m) | $2.16B | (m) | 0.49% | (m) | Reported |
| 2025-03-31 | (m) | $71.58B | $371.00M | (m) | $2.10B | (m) | 0.52% | (m) | Reported |
| 2024-12-31 | (m) | $70.60B | $360.00M | (m) | $2.06B | (m) | 0.51% | (m) | Reported |
| 2024-09-30 | (m) | $69.62B | $332.00M | (m) | $2.02B | (m) | 0.48% | (m) | Reported |
| 2024-06-30 | (m) | $68.35B | $328.00M | (m) | $1.99B | (m) | 0.48% | (m) | Reported |
| 2024-03-31 | (m) | $66.72B | $272.00M | (m) | $1.97B | (m) | 0.41% | (m) | Reported |
| 2023-12-31 | (m) | $64.97B | $262.00M | (m) | $1.94B | (m) | 0.40% | (m) | Reported |
| 2023-09-30 | (m) | $63.16B | $288.00M | (m) | $1.90B | (m) | 0.46% | (m) | Reported |
| 2023-06-30 | (m) | $61.92B | $303.00M | (m) | $1.86B | (m) | 0.49% | (m) | Reported |
| 2023-03-31 | (m) | $60.88B | $332.00M | (m) | $1.81B | (m) | 0.55% | (m) | Reported |
| 2022-12-31 | (m) | $60.23B | $341.00M | (m) | $1.74B | (m) | 0.57% | (m) | Reported |
| 2022-09-30 | (m) | $59.80B | $357.00M | (m) | $1.69B | (m) | 0.60% | (m) | Reported |
| 2022-06-30 | (m) | $60.10B | $385.00M | (m) | $1.64B | (m) | 0.64% | (m) | Reported |
| 2022-03-31 | (m) | $59.72B | $429.00M | (m) | $1.59B | (m) | 0.72% | (m) | Reported |
| 2021-12-31 | (m) | $58.75B | $440.00M | (m) | $1.57B | (m) | 0.75% | (m) | Reported |
| 2021-09-30 | (m) | (m) | $474.00M | (m) | $1.55B | (m) | (m) | (m) | Reported |
| 2021-06-30 | (m) | (m) | $440.00M | (m) | $1.54B | (m) | (m) | (m) | Reported |
| 2021-03-31 | (m) | (m) | $377.00M | (m) | $1.54B | (m) | (m) | (m) | Reported |
| 2020-12-31 | (m) | (m) | $362.00M | (m) | $1.58B | (m) | (m) | (m) | Reported |
| 2020-09-30 | (m) | (m) | $313.00M | (m) | $1.64B | (m) | (m) | (m) | Reported |
| 2020-06-30 | (m) | (m) | $337.00M | (m) | $1.70B | (m) | (m) | (m) | Reported |
| 2020-03-31 | (m) | (m) | $367.00M | (m) | $1.79B | (m) | (m) | (m) | Reported |
| 2019-12-31 | (m) | (m) | $347.00M | (m) | $1.82B | (m) | (m) | (m) | Reported |
| 2019-09-30 | (m) | (m) | $327.00M | (m) | $1.83B | (m) | (m) | (m) | Reported |
| 2019-06-30 | (m) | (m) | $292.00M | (m) | $1.83B | (m) | (m) | (m) | Reported |
| 2019-03-31 | (m) | (m) | $270.00M | (m) | $1.78B | (m) | (m) | (m) | Reported |
| 2018-12-31 | (m) | (m) | $268.00M | (m) | $1.75B | (m) | (m) | (m) | Reported |
| 2018-09-30 | (m) | (m) | $279.00M | (m) | $1.74B | (m) | (m) | (m) | Reported |
| 2018-06-30 | (m) | (m) | $264.00M | (m) | $1.73B | (m) | (m) | (m) | Reported |
| 2018-03-31 | (m) | (m) | $257.00M | (m) | $1.70B | (m) | (m) | (m) | Reported |
| 2017-12-31 | (m) | (m) | $270.00M | (m) | $1.69B | (m) | (m) | (m) | Reported |
| 2017-09-30 | (m) | (m) | $250.00M | (m) | $1.69B | (m) | (m) | (m) | Reported |
| 2017-06-30 | (m) | (m) | $262.00M | (m) | $1.69B | (m) | (m) | (m) | Reported |
| 2017-03-31 | (m) | (m) | $259.00M | (m) | $1.71B | (m) | (m) | (m) | Reported |
| 2016-12-31 | (m) | (m) | $251.00M | (m) | $1.71B | (m) | (m) | (m) | Reported |
| 2016-09-30 | (m) | (m) | $264.00M | (m) | $1.69B | (m) | (m) | (m) | Reported |
| 2016-06-30 | (m) | (m) | $265.00M | (m) | $1.66B | (m) | (m) | (m) | Reported |
| 2016-03-31 | (m) | (m) | $256.00M | (m) | $1.66B | (m) | (m) | (m) | Reported |
| 2015-12-31 | (m) | (m) | $239.00M | (m) | $1.67B | (m) | (m) | (m) | Reported |
| 2015-09-30 | (m) | (m) | $216.00M | (m) | $1.68B | (m) | (m) | (m) | Reported |
| 2015-06-30 | (m) | (m) | $189.00M | (m) | $1.70B | (m) | (m) | (m) | Reported |
| 2015-03-31 | (m) | (m) | $174.00M | (m) | $1.70B | (m) | (m) | (m) | Reported |
| 2014-12-31 | (m) | (m) | $163.00M | (m) | $1.74B | (m) | (m) | (m) | Reported |
| 2014-09-30 | (m) | (m) | $150.00M | (m) | $1.77B | (m) | (m) | (m) | Reported |
| 2014-06-30 | (m) | (m) | $139.00M | (m) | $1.80B | (m) | (m) | (m) | Reported |
| 2014-03-31 | (m) | (m) | $127.00M | (m) | $1.84B | (m) | (m) | (m) | Reported |
| 2013-12-31 | (m) | (m) | $113.00M | (m) | $1.85B | (m) | (m) | (m) | Reported |
| 2013-09-30 | (m) | (m) | $98.00M | (m) | $1.85B | (m) | (m) | (m) | Reported |
| 2013-06-30 | (m) | (m) | $84.00M | (m) | $1.84B | (m) | (m) | (m) | Reported |
| 2013-03-31 | (m) | (m) | $70.00M | (m) | $1.83B | (m) | (m) | (m) | Reported |
| 2012-12-31 | (m) | (m) | $56.00M | (m) | $1.80B | (m) | (m) | (m) | Reported |
| 2012-09-30 | (m) | (m) | $41.00M | (m) | $1.80B | (m) | (m) | (m) | Reported |
| 2012-06-30 | (m) | (m) | $33.00M | (m) | $1.87B | (m) | (m) | (m) | Reported |
| 2012-03-31 | (m) | (m) | $27.00M | (m) | $1.95B | (m) | (m) | (m) | Reported |
| 2011-12-31 | (m) | (m) | $26.00M | (m) | $2.04B | (m) | (m) | (m) | Reported |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | $32.00M | (m) | $2.10B | (m) | (m) | (m) | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $40.00M | (m) | $1.99B | (m) | (m) | (m) | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENET HEALTHCARE CORP (THC) | United States | $20.097B | |
| Surgery Partners, Inc. (SGRY) | United States | $1.860B | -24.80 |
| Ardent Health, Inc. (ARDT) | United States | $1.478B | 17.91 |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | United States | $0.405B | 1.87 |